Clinical Trials
12 trialsNCT02761889 2026-05-12
Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer
Fundacao Champalimaud
Phase NA Completed
NCT01517451 2026-02-11
Radiation and Androgen Ablation for Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT02203695 2025-10-28
Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04909294 2024-02-13
STEREO-RML
Centre Georges Francois Leclerc
Phase NA Active not recruiting
NCT03535675 2023-05-22
Muscadine Plus (MPX) In Men With Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 3 Terminated
NCT03327662 2021-01-06
CTC-STOP
Institute of Cancer Research, United Kingdom
Phase 3 Terminated
NCT01832259 2018-12-12
A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection
University of Utah
Phase 2 Completed
NCT01795365 2018-09-28
Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer
Centre Hospitalier Universitaire Vaudois
Phase NA Terminated
NCT02525068 2018-08-08
RE-AKT
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT00243321 2017-07-13
High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer
Virginia Commonwealth University
Phase NA Completed
NCT01368003 2015-09-01
STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling
Dana-Farber Cancer Institute
Phase 2 Withdrawn
NCT00608920 2013-05-24
SPECT
Washington University School of Medicine
Phase NA Completed